Luo, Y.N., Lu, J., Liang, G.H. and Ma, W.H. (2025) Long-Term Opacity of Intraocular Lens after Cataract Surgery in 1 Case. Journal of Biosciences and Medicines, 13, 206-214. doi: ...

The iDose platform is designed to address ubiquitous patient non-adherence and chronic side effects associated with topical ...

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from ...

Corporation announced several positive clinical updates for its iDose sustained-release procedural pharmaceutical platform, ...

NYSE:GKOS) Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with heart disease.

Product Development Science & Technology, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States ...

Read more. Timolol microdrops appear as effective as conventional drops in lowering IOP Timolol maleate 0.5% microdrops delivered with the Nanodropper Adaptor met three noninferiority endpoints in ...